@article {1908, title = {Increased Risk of Tumor Necrosis Factor-Alpha Levels in Adult Patients with Malignancy Receiving Non-Leucodepleted Packed Red Cells Transfusion}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {December 2022}, pages = {778-781}, type = {Original Article }, chapter = {778}, abstract = {

Background and Objectives: Blood transfusion in patients with malignancy may evoke transfusion reactions. Leukocyte, as a major producer of cytokines, including Tumor Necrosis Factor-alpha (TNF-alpha), is considered to correlate to transfusion reactions. This study aims to determine the risk of increased TNFalpha in adult patients with malignancy who received non-leucodepleted (nLD) erythrocyte transfusion compared to those receiving leucodepleted (LD) Packed Red Cells (PRC) transfusion. Materials and Methods: This quasi-experimental study was conducted on adult patients with malignancy who required PRC transfusion and underwent outpatient treatment. The patients were divided without randomization into nLD and LD groups, and then their pre-transfusion TNF-alpha levels and the post-transfusion changes were examined. Results: This study included thirty-one patients fulfilling the inclusion criteria. The TNFalpha levels in nLD and LD groups after transfusion increased significantly (p \< 0.05), i.e., from 0.81 (0.2 - 4.2) pg/mL and 1.7 (0.15 - 6.3) pg/mL to 10.1 (1.4 - 28.9) and 5.9 (0.95 - 12.9) pg/mL. There was no significant difference in the pre-transfusion median TNF-alpha levels between the nLD and LD groups (p = 0.122). However, the post-transfusion median TNF-alpha levels of the nLD group were significantly higher (p = 0.024). It indicated that the increase in TNF-alpha levels is associated with nLD blood products transfused. The Relative Risk of the increased TNF-alpha levels in nLD-PRC transfusion was 2.01 (95\% Confidence Interval: 1,153-3,502). Conclusion: nLD-PRC transfusion poses a 2.01 times risk for increased TNF-alpha levels compared to LD-PRC transfusion.

}, keywords = {Malignancy, Non-leucodepleted, PRC transfusion, Relative risk, TNF-Alpha}, doi = {10.5530/pj.2022.14.167}, author = {Teguh Triyono and Bambang Hendriawan Prasaja Jati and Usi Sukorini} } @article {1324, title = {Tinospora Sinensis (Lour.) Merr. Stem Modulate The TNF-Alpha Expression In HCT- 116 Tumour Cell, Besides the Inhibitory Effect on Cervical, Colon and Breast Cancer Cell Lines and Mycobacterium Tuberculosis H37Rv}, journal = {Pharmacognosy Journal}, volume = {13}, year = {2021}, month = {January 2021}, pages = {8-16}, type = {Original Article}, chapter = {8}, abstract = {

Background: The present study was designed to evaluate TNF-Alpha experession, anticancer and antitubercular properties for the stem extracts of Tinospora sinensis (TS). Objective: natural product research is widely used for identifying hit molecules for life threatening diseases including cancer, tuberculosis and drug resistant infections. Materials and Methods: There were three polarity dependant solvent extracts obtained through cold maceration process using ethanol (ELTS), ethyl acetate (EATS) and n-hexane (NHTS), respectively. The extracts were subjected to MTT assay for their anticancer potential against HeLa (cervical cancer), MCF-7 (breast cancer) and HCT116 (colon cancer) cell lines, and based on the results, NHTS was subjected to flow cytometry for TNF-Alpha expression in HCT-116 cells. The antitubercular activity for the extracts was performed against Mycobacterium tuberculosis H37Rv (Mtb) by luciferase reporter phage (LPS) assay method. Results: The result of anticancer screening revealed that n-hexane extracts showed the significant inhibition (p\<0.05) on HCT-116 cells with the IC50 of 177.4 μg/ml, whereas EATS and ELTS were equally active on HeLa with the respective IC50 of 236 and 277 μg/ml. The NHTS was significantly effective on decreasing (P\<0.05) TNF-Alpha expression (31.27 MFU) in HCT-116 cells and is closely active with standard simvastatin (26.7 MFU) against the control (7.06 MFU). The antitubercular activity results revealed the equi-potency of both NHTS and EATS on Mtb with growth inhibition of 84 \% at 100μg/ml. The GC-MS analyses of NHTS confirmed the presence of Berberine, palmatine, tembertarine, magniflorine, choline and tinosporin. Conclusion: Overall, we scientifically support the traditional use Tinospora sinensis stem in the treatment of cancer and immune diseases.

}, keywords = {Anticancer, Antitubercular, HCT-116, Immunomodulatory, Tinospora sinensis, TNF-Alpha}, doi = {10.5530/pj.2021.13.2}, author = {Sreelakshmi Bada Venkatappa Gari and Ramalingam Peraman} }